Bryce Point Capital »

United Therapeutics Corporation shares owned by Bryce Point Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Bryce Point Capital from 13F filings

Historical chart of Bryce Point Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Bryce Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Bryce Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $572k 1.4k 419.21

More positions owned by Bryce Point Capital

Freshpet (FRPT)
Wayfair Cl A (W)
Teleflex Incorporated (TFX)
Transmedics Group (TMDX)
Option Care Health Com New (OPCH)
Bright Horizons Fam Sol In D (BFAM)
Tecnoglass Ord Shs (TGLS)
Valvoline Inc Common (VVV)
Alight Com Cl A (ALIT)
Hayward Hldgs (HAYW)
Scotts Miracle-gro Cl A (SMG)
Carvana Cl A (CVNA)
Globalstar Com New (GSAT)
Chemours (CC)
Casella Waste Sys Cl A (CWST)

View all positions for Bryce Point Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation